Low serum testosterone is associated with tumor aggressiveness and poor prognosis in prostate cancer

Serum testosterone is a potential marker to distinguish between indolent and aggressive prostate cancer (PCa). The present study aimed to investigate whether low levels of total serum testosterone at diagnosis were associated with aggressive PCa and poor clinical outcomes. In total, 762 non-Hispanic...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncol Lett
Autors principals: Tu, Huakang, Gu, Jian, Meng, Qing H., Kim, Jeri, Strom, Sara, Davis, John W., He, Yonggang, Wagar, Elizabeth A., Thompson, Timothy C., Logothetis, Christopher J., Wu, Xifeng
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2017
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5403694/
https://ncbi.nlm.nih.gov/pubmed/28454349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.5616
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars